Atrial fibrillation in myocardial infarction patients: Impact on health care utilization

Alanna M Chamberlain1, Suzette J Bielinski, Susan A Weston

  • 1Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

American Heart Journal
|October 8, 2013
PubMed

Insights

Atrial fibrillation (AF) increases healthcare use after myocardial infarction (MI). Late-onset AF poses the highest risk for hospitalizations and visits, highlighting the need for AF management in MI patients.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Atrial fibrillation (AF) is a common complication of myocardial infarction (MI).
  • While AF is known to worsen survival rates in MI patients, its effect on healthcare utilization remains understudied.

Purpose of the Study:

  • To investigate the association between different timings of AF onset and healthcare utilization in patients following a myocardial infarction.

Main Methods:

  • A community-based cohort study in Olmsted County, Minnesota, assessed incident MI patients.
  • The study evaluated the risk of hospitalizations, emergency department (ED) visits, and outpatient visits based on prior, new-onset (<30 days post-MI), and late-onset (≥30 days post-MI) AF.

Main Results:

  • Patients with prior AF and new-onset AF showed increased hospitalization risks (1.6-fold and 1.3-fold, respectively).
  • Late-onset AF was associated with a 2.2-fold increased risk of hospitalization and significantly elevated risks for ED and outpatient visits.
  • Even after adjusting for recurrent MI and heart failure, late-onset AF patients maintained a >50% increased risk for hospitalizations and ED visits.

Conclusions:

  • The timing of atrial fibrillation onset significantly influences healthcare utilization following myocardial infarction.
  • Late-onset AF presents the highest risk, emphasizing the critical need for proactive AF management in MI survivors.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...